Dose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled-analysis of an Asian Liver Radiation Therapy Group study.

Kim N.CHIA-HSIEN CHENGHuang W.-Y.Kimura T.Zeng Z.C.Lee V.H.F.Kay C.S.Seong J.2021-02-032021-02-0320210360-3016https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097435926&doi=10.1016%2fj.ijrobp.2020.09.038&partnerID=40&md5=f59dc61e025dfc3178c3b016a9f5f4bdhttps://scholars.lib.ntu.edu.tw/handle/123456789/546324Purpose: Despite the worldwide implementation of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC), there is a lack of consensus guideline on prescription dose. Herein, this multinational study aimed to investigate the effects[SDGs]SDG3[SDGs]SDG16Patient monitoring; Radiation effects; Tumors; Biologically effective dose; Dose response relationships; Hepatocellular carcinoma; Local tumor progressions; Methods and materials; Multivariable analysis; Propensity score matching; Stereotactic body radiatDose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled-analysis of an Asian Liver Radiation Therapy Group study.journal article10.1016/j.ijrobp.2020.09.038332291652-s2.0-85097435926